AMN Healthcare AMN Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period at other companies
Other financials
Where this comes from
Reported directly by AMN Healthcare in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod.
The official record: AMN Healthcare’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about AMN Healthcare's share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AMN Healthcare's share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period?
- AMN Healthcare (AMN) reported share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period of 167K in Q4 2025.
- How has AMN Healthcare's share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period changed year-over-year?
- AMN Healthcare's share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period increased by 7.1% year-over-year, from 156K to 167K.
- What does share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period mean?
- This metric quantifies the number of non-option equity awards that were forfeited by employees during the period, typically due to departures or failure to meet performance conditions. A high level of forfeitures can indicate significant employee turnover or overly aggressive performance targets.